SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?


To: Bucky Katt who wrote (24612)6/28/2005 1:11:49 PM
From: Skywatcher  Respond to of 48463
 
putting some more MAD money in MADCATZ at 1.18
TISA bought at 2.80
SFLK looks to be rising from the hole of dilution



To: Bucky Katt who wrote (24612)6/28/2005 2:52:53 PM
From: Skywatcher  Respond to of 48463
 
this flea bag dog might get some legs with GE behind the sales
China Approves Cardiac Science Devices
Tuesday June 28, 12:30 pm ET
Chinese Regulators Approve Cardiac Science's Latest Line of Automatic External Defibrillators

IRVINE, Calif. (AP) -- Cardiac Science Inc. said Tuesday that Chinese regulators approved its latest line of automatic external defibrillators, devices that monitor a patient's heartbeat and provide defibrillation as necessary to keep its rhythm steady.

The company's shares rose 9 cents, or 9.4 percent, to $1.04 in midday trading on the Nasdaq. The stock has traded as high as $3.42 within the past 52 weeks, but has spent much of the past few months below $1.

Hospitals use Cardiac's products to monitor and automatically treat patients with life-threatening heart rhythm irregularities. More than 100 of the earlier-generation devices are currently used in Chinese hospitals, Cardiac Science said.

The company sells the majority of its products in the United States, though international sales account for about 40 percent of its revenue.



To: Bucky Katt who wrote (24612)6/28/2005 3:02:53 PM
From: Skywatcher  Respond to of 48463
 
this flea bag dog might get some legs with GE behind the sales
China Approves Cardiac Science Devices
Tuesday June 28, 12:30 pm ET
Chinese Regulators Approve Cardiac Science's Latest Line of Automatic External Defibrillators

IRVINE, Calif. (AP) -- Cardiac Science Inc. said Tuesday that Chinese regulators approved its latest line of automatic external defibrillators, devices that monitor a patient's heartbeat and provide defibrillation as necessary to keep its rhythm steady.

The company's shares rose 9 cents, or 9.4 percent, to $1.04 in midday trading on the Nasdaq. The stock has traded as high as $3.42 within the past 52 weeks, but has spent much of the past few months below $1.

Hospitals use Cardiac's products to monitor and automatically treat patients with life-threatening heart rhythm irregularities. More than 100 of the earlier-generation devices are currently used in Chinese hospitals, Cardiac Science said.

The company sells the majority of its products in the United States, though international sales account for about 40 percent of its revenue.